Inbrain plans to use the investment to accelerate clinical trials and expand its product portfolio, focusing on conditions like epilepsy and Parkinson's disease. Spot AI raised $31 million in Series B ...
We sell different types of products and services to both investment ... we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and ...
We sell different types of products and services to both investment ... we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and ...